Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04193631 · ClinicalTrials.gov registry record · Phase 1
Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain
A Phase 1 study, sponsored by Pure Green.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT04193631 is a Phase 1 study that has completed, run by Pure Green. The registered enrollment target is 16 participants.
The verdict
NCT04193631, a Phase 1 study, has completed, sponsored by Pure Green.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate whether Pure Green tablets is a better pain reliever for the treatment of mild to moderate musculoskeletal pain.
Interventions
- DRUG Cannabidiol (CBD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-12-07 |
| Est. Completion | 2019-12-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04193631
The ClinicalTrials.gov registry entry for NCT04193631 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pure Green, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabidiol (CBD) is the first listed.
NCT04193631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04193631 about?
NCT04193631 is a clinical study titled "Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain". The purpose of the study is to evaluate whether Pure Green tablets is a better pain reliever for the treatment of mild to moderate musculoskeletal pain.
What is the current status of trial NCT04193631?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2019-12-07. Estimated completion is 2019-12-09.
What interventions are being tested in trial NCT04193631?
The interventions under investigation include: Cannabidiol (CBD) (DRUG).
Who is sponsoring clinical trial NCT04193631?
This trial is sponsored by Pure Green, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.